Read Gene Spolka Akcyjna Logo

Read Gene Spolka Akcyjna

Develops DNA tests to identify genetic cancer risk for early detection and prevention.

RDG | WAR

Overview

Corporate Details

ISIN(s):
PLRADGN00014 (+1 more)
LEI:
2594003D7O7NDUV8GE29
Country:
Poland
Address:
Dobra Grzepnica-Alabastrowa 8, 72-003 Dobra
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Read-Gene S.A. is an innovative biotechnology company focused on the commercialization of methods for the detection, prevention, and treatment of malignant tumors. Established in 2005, the company's core operations are centered on three complementary segments: genetic testing, chemoprevention, and clinical trials. It develops and provides advanced DNA tests that identify genetic predispositions to cancer, enabling precise prophylaxis and facilitating earlier treatment. Additionally, the company offers advisory and support services for oncological genetic counseling centers. Read-Gene is distinguished by its strong scientific foundation, with a team of renowned scientists from the International Hereditary Cancer Center, and holds numerous patents for its novel cancer risk assessment technologies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-25 10:54
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.0 KB
2024-03-25 10:51
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.1 KB
2023-11-22 16:45
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-11-16 17:31
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-10-26 16:35
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-07 12:11
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.4 KB
2023-08-07 12:08
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.8 KB
2023-08-07 12:04
Registration Form
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-07 12:01
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-02 13:48
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.1 KB
2023-08-02 13:45
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-01 15:06
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-01 15:04
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-06-30 17:30
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na ZWZ READ-GENE S.A. w…
Polish 584 bytes
2023-06-29 13:27
Director's Dealing
powiadomienie_o_transakcjach_-_zmiana.pdf
Polish 11.9 KB

Automate Your Workflow. Get a real-time feed of all Read Gene Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Read Gene Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Israel TMIS
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
VERICI DX PLC Logo
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom VRCI
Vicore Pharma Holding Logo
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden VICO
R&D in renewable energy & manufacturing specialized tools for automotive & engineering.
Slovakia N/A
Xlife Sciences AG Logo
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland XLS
Yoshi Innovation Spolka Akcyjna Logo
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland YOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.